Sadeem Mahmood, MD
Cardiovascular Disease · Pine Bluff, ARNPI 1245299924
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $8,488 of the $10,683 with a category attached, or 79.5%. It is spread thinly across 38 manufacturers, the largest accounting for just 17.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $2,322 and has fallen 53.3% since, to $1,084 in 2025.
Across 326 payments — averaging $32.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Biotronik Inc.$2K
- Abbott$2K
- Terumo Medical Corporation$700
- Amgen$590
- Siemens Medical Solutions USA, Inc.$533
- plus $4K from 32 others
Across 1 payment — averaging $2368.44 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$2K
What the payments were for
- Consulting fees$7007%
- Travel & lodging$1,47814%
- Food & beverage$8,48879%
- Education$170%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 20 | $1,853 |
| Biotronik Inc. | 41 | $1,798 |
| Abbott | 39 | $1,618 |
| Terumo Medical Corporation | 1 | $700 |
| Amgen | 36 | $590 |
| Siemens Medical Solutions USA, Inc. | 6 | $533 |
| Novartis | 40 | $440 |
| Johnson & Johnson | 26 | $377 |
| Merck | 18 | $339 |
| Cardiovascular Systems Inc. | 15 | $312 |
| Philips North America LLC | 11 | $297 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 16 | $198 |
| Cook Medical LLC | 2 | $191 |
| Vivaquant Inc, Dba Rhythm Express | 1 | $186 |
| Boehringer Ingelheim | 3 | $150 |
| Boston Scientific | 6 | $137 |
| GE HealthCare | 1 | $106 |
| Shockwave Medical, Inc | 1 | $103 |
| Lexicon Pharmaceuticals, Inc. | 5 | $96 |
| Cvrx, Inc. | 1 | $91 |
| AstraZeneca | 5 | $65 |
| Sanofi-aventis U.S. LLC | 4 | $60 |
| Irhythm Technologies, Inc. | 3 | $54 |
| Amarin Pharma, Inc. | 3 | $54 |
| E.r. Squibb & Sons, L.L.C. | 3 | $51 |
| Alnylam Pharmaceuticals Inc. | 2 | $46 |
| Pfizer | 3 | $35 |
| Regeneron Healthcare Solutions, Inc. | 2 | $28 |
| Novo Nordisk | 1 | $22 |
| Abiomed | 1 | $21 |
| Catheter Precision, Inc. FKA Ra Medical Systems, Inc. | 2 | $21 |
| Biocompatibles, Inc. | 1 | $20 |
| Intact Vascular, Inc. | 1 | $19 |
| Astellas Pharma US Inc | 1 | $19 |
| Paratek Pharmaceuticals, Inc. | 1 | $19 |
| Bardy Diagnostics, Inc. | 1 | $15 |
| Chiesi USA, Inc. | 1 | $12 |
| Venclose Inc. | 2 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Micra$1,307
- Navicross$700
- BioMonitor$286
- Orsiro Mission$272
- Diamondback Peripheral$263
- Acticor 7 VR-T DX$252
- RHYTHM EXPRESS$186
- XIENCE SKYPOINT$177
- Artis zee multi-purpose$169
- Cios Alpha$169
- Fortify Assura, Ellipse ICD$161
- Cios Fusion$150
- Cios Select$150
- Protego$148
- PK Papyrus$142
- Passeo-18$142
- PRO-Kinetic Energy$142
- MitraClip System$141
- Rivacor$138
- Solia$138
How this compares
$10,683 in reported general payments places this provider in the 80th percentile of 130 cardiovascular disease providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 264 | $166,307 |
| EntrestoSacubitril/Valsartan | 86 | $84,071 |
| EliquisApixaban | 42 | $32,838 |
| FarxigaDapagliflozin Propanediol | 29 | $24,261 |
| Repatha SureclickEvolocumab | 21 | $22,485 |
| JardianceEmpagliflozin | 23 | $18,144 |
| Praluent PenAlirocumab | 14 | $10,421 |
| BrilintaTicagrelor | 14 | $9,841 |
| Repatha SyringeEvolocumab | 11 | $9,552 |
| Ranolazine ErRanolazine | 33 | $2,072 |
| ClopidogrelClopidogrel Bisulfate | 353 | $1,978 |
| Nebivolol Hcl | 36 | $1,188 |
| Metoprolol Succinate | 83 | $939 |
| Valsartan | 34 | $895 |
| Rosuvastatin Calcium | 126 | $811 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $377 | $166,307264 claims |
| NovartisEntresto | $440 | $84,07186 claims |
| AstraZenecaFarxiga, Brilinta | $65 | $34,10243 claims |
| PfizerEliquis | $35 | $32,83842 claims |
| Boehringer IngelheimJardiance | $150 | $18,14423 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 130 cardiovascular disease providers in Arkansas.
Other cardiovascular disease in Pine Bluff
- Nicholas WillisPine Bluff$15K
- Ricki FramPine Bluff$6K
- Shabbir DharamseyPine Bluff$6K
- Ian CawichLittle Rock$294K
- Barry TedderJonesboro$130K
- Harvinder DodEl Dorado$126K
- William RollefsonLittle Rock$74K
- Andre PaixaoLittle Rock$73K
- Julio SchwarzFort Smith$70K
- Maximiliano ArroyoJonesboro$46K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.